Evidence map›Paper›PMID 32301581›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2020

Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues.

Satoshi Muraoka, Annina M DeLeo, Manveen K Sethi, Kayo Yukawa-Takamatsu, Zijian Yang, Jina Ko, John D Hogan, Zhi Ruan, Yang You, Yuzhi Wang and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 2 syntheses or guidelines pooled it, 187 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Extracellular vesicles for delivery of functional telomerase.Cell communication and signaling : CCS · 2025
    Article
  18. Article
  19. Article
  20. Review

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Satoshi MuraokaDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA.
Annina M DeLeoDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA.
Manveen K SethiDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, USA.
Kayo Yukawa-TakamatsuDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA.
Zijian YangDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jina KoDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
John D HoganProgram in Bioinformatics, Boston University, Boston, Massachusetts, USA.
Zhi RuanDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA.
Yang YouDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA.
Yuzhi WangDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA.
Maria MedallaDepartment of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Seiko IkezuDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA.
Mei ChenGeriatric Research, Education and Clinical Center, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, Massachusetts, USA.
Weiming XiaDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA.
Santhi GorantlaDepartment of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Howard E GendelmanDepartment of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.
David IssadoreDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Joseph ZaiaDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, USA.
Tsuneya IkezuDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-3979-8596
Boston University · USUniversity of Pennsylvania · USUniversity of Nebraska Medical Center · USEdith Nourse Rogers Memorial Veterans Hospital · US

Funding

Exosome-mediated propagation of pathogenic tau proteinRF1AG054199 · NIA · MAYO CLINIC JACKSONVILLE · PI IKEZU, TSUNEYA · 2016 to 2021
$5.0M
Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimer’s diseaseR01AG054672 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI BUTOVSKY, OLEG, IKEZU, TSUNEYA · 2017 to 2021
$4.1M
Targeting emerging P2RX7 signaling pathways in animal models of Alzheimer's diseaseR01AG066429 · NIA · MAYO CLINIC JACKSONVILLE · PI IKEZU, TSUNEYA · 2020 to 2024
$2.0M
Methods for determination of glycoprotein glycosylation similarities among disease statesR01GM133963 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ZAIA, JOSEPH · 2019 to 2021
$1.4M
An open-source software suite for processing glycomics and glycoproteomics mass spectral dataU01CA221234 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ZAIA, JOSEPH · 2017 to 2019
$1.2M
Biogenesis of Exosomes, Secretion, and Trafficking in Alzheimer's DiseaseR56AG057469 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOOK, VIVIAN Y. H, IKEZU, TSUNEYA · 2017 to 2017
$833k
A Thermo-Fisher Scientific Q-Exactive HF Mass Spectrometry SystemS10OD021651 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ZAIA, JOSEPH · 2016 to 2016
$580k
Identification of exosome signature in serum from ALS patientsR21NS104609 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI BERRY, JAMES DALE, BUTOVSKY, OLEG · 2018 to 2019
$543k
NCI NIH HHS U01 CA221234NIA NIH HHS R01 AG054672NIA NIH HHS R01 AG066429NIA NIH HHS R56 AG057469NIA NIH HHS RF1 AG054199NIGMS NIH HHS R01 GM133963NIH HHS S10 OD021651NINDS NIH HHS R21 NS104609
6 · The paper itself

Abstract

introductionExtracellular vesicles (EVs) from human Alzheimer's disease (AD) biospecimens contain amyloid beta (Aβ) peptide and tau. While AD EVs are known to affect brain disease pathobiology, their biochemical and molecular characterizations remain ill defined.

methodsEVs were isolated from the cortical gray matter of 20 AD and 18 control brains. Tau and Aβ levels were measured by immunoassay. Differentially expressed EV proteins were assessed by quantitative proteomics and machine learning.

resultsLevels of pS396 tau and Aβ1-42 were significantly elevated in AD EVs. High levels of neuron- and glia-specific factors are detected in control and AD EVs, respectively. Machine learning identified ANXA5, VGF, GPM6A, and ACTZ in AD EV compared to controls. They distinguished AD EVs from controls in the test sets with 88% accuracy. DISCUSSION: In addition to Aβ and tau, ANXA5, VGF, GPM6A, and ACTZ are new signature proteins in AD EVs.

Indexed as

ProteomeAgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesBrainExtracellular VesiclesFemaleHumansMachine LearningMalePhosphorylationProteomicstau ProteinsAmyloid beta-PeptidesProteometau ProteinsAlzheimer's diseaseamyloid beta peptidecortical gray matterextracellular vesiclesmachine learningmicrotubule-associated protein tauproteome

Identifiers

PMID32301581
PMCPMC7293582
OpenAlexW3017163794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.